checkAd

     133  0 Kommentare Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting - Seite 2

    “Xenon” and the Xenon logo are registered trademarks or trademarks of Xenon Pharmaceuticals Inc. in various jurisdictions. All other trademarks belong to their respective owner.

    Contacts:
    For Investors:
    Chad Fugere
    Vice President, Investor Relations
    (857) 675-7275
    investors@xenon-pharma.com

    Lesen Sie auch

    For Media:
    Jodi Regts
    Xenon Corporate Affairs
    (604) 484-3353
    media@xenon-pharma.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 2 von 2

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Xenon Pharmaceuticals Showcases XEN1101 at the American Academy of Neurology 2024 Annual Meeting - Seite 2 VANCOUVER, British Columbia, April 16, 2024 (GLOBE NEWSWIRE) - Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a neuroscience-focused biopharmaceutical company, announced two oral presentations highlighting XEN1101 clinical data at the American Academy …

    Auch bei Lesern beliebt

    Schreibe Deinen Kommentar

    Disclaimer